Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Adam Albaba

Foot and Ankle Surgery Seattle, WA Medical Doctor

NPI 1831533207 CMS profile 5703978

325 9Th Ave, Seattle, WA 98104

Open in the dashboard

General payments

$45,957

129 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Adam Albaba of Seattle, WA is reported in the CMS Open Payments database as having received $45,957 across 129 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Foot and Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $386 3
2022 General $9,647 50
2021 General $9,105 31
2020 General $25,130 5
2019 General $1,689 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Albaba
  • Foot and Ankle Surgery median
  • Middle half of Foot and Ankle Surgery
  • National median

In program year 2025, general payments to Adam Albaba were reported at $0. Among 650 Foot and Ankle Surgery profiles paid that year, the median was $1,183 and the middle half received between $267 and $6,309.

Show as a table
Year Adam Albaba Foot and Ankle Surgery median Middle half National median
2019 $1,689 $1,327 $279–$5,421 $163
2020 $25,130 $795 $121–$3,473 $114
2021 $9,105 $1,289 $201–$4,963 $132
2022 $9,647 $1,539 $270–$6,067 $149
2023 $386 $1,117 $257–$5,264 $160
2024 $0 $1,064 $235–$4,944 $164
2025 $0 $1,183 $267–$6,309 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Arthrex, Inc. $27,077 46 payments
  2. Smith+Nephew, Inc. $7,500 2 payments
  3. Medical Device Business Services, Inc. $3,605 26 payments
  4. Djo, LLC $3,000 4 payments
  5. Stryker Corporation $1,868 29 payments
  6. Paragon 28, Inc. $1,773 8 payments
  7. CGG Medical Inc $617 1 payment
  8. Integra LifeSciences Corporation $391 5 payments
  9. Acell, Inc. $69 3 payments
  10. DePuy Synthes Sales Inc. $27 2 payments
  11. Other $31 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Grant $23,000 5 payments
  2. Education $13,067 8 payments
  3. Travel and Lodging $7,019 30 payments
  4. Food and Beverage $2,872 86 payments
Products named General payments · program years 2019–2023
  1. Product Portfolio $1,773 8 payments
  2. MILAGRO $801 7 payments
  3. GRYPHON $801 7 payments
  4. NA $659 1 payment
  5. PANTA NAIL $391 5 payments
  6. HALLU-LOCK $391 5 payments
  7. TOTAL FOOT SYSTEM $391 5 payments
  8. CADENCE ANKLE REPLACEMENT SYSTEM $391 5 payments
  9. SALTO TALARIS TOTAL ANKLE PROSTHESIS $391 5 payments
  10. SALVATION $311 3 payments
  11. Other $983 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

129 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Foot and Ankle Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record